Skip to content

Effect of Super-Oxygenated Water on Blood Oxygen Saturation

A Randomized, Double-blinded and Placebo-controlled Study on Super-Oxygenated Water

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07016191
Enrollment
60
Registered
2025-06-11
Start date
2025-05-01
Completion date
2025-11-28
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult Subject

Keywords

Inhale, Super-oxygenated Water, Superoxygenated Water, Blood Oxygen Saturation

Brief summary

Therapeutic delivery of additional Oxygen to blood stream via hyperbaric and extracorporeal oxygenation that raises blood Oxygen saturation level, apart from oxygenation in the lungs, is known to induce tissue repair, restore normal body functions and improve survival. Despite the clinical benefits obtained from these interventions, Oxygen supplementation is rather a medically involved process requiring access to specialized equipment including hyperbaric chambers, cardiac catheterization laboratory and extracorporeal oxygenators, and is not generally amenable for everyday use. The current prospective study will evaluate a non-invasive route for Oxygen delivery through ingestion of super-oxygenated water in adult volunteers. The participants will be randomly assigned to one of the two study groups viz. Inhale super-oxygenated water or placebo control normal water at 1:1 ratio. Neither the participants nor the study doctor will know the treatment assignment. Pre- and post-ingestion measurements will be conducted to evaluate effect of super-oxygenated water.

Detailed description

Participants will drink 12 oz of their assigned water (Inhale water or source and taste matched normal water). Baseline blood Oxygen saturation and Heart rate will be measured by a pulse oximeter immediately prior to water ingestion. At one-minute post-ingestion, the blood Oxygen saturation and Heart rate will be measured to compare changes over the baseline. Assessment of Energy level and Brain clarity will be performed as a participant reported outcome measure conducted at pre- and post-ingestion time points through questionnaire.

Interventions

Ingestion of Super-Oxygenated or Normal water

Sponsors

Inhale, Inc
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Legally adult (18 years of age or older) * Subject must be willing to review and provide a written informed consent * Subject must agree to the study procedures including water ingestion, and SPO2 and heart rate measurements

Exclusion criteria

* Any active and life-threatening medical condition involving hepatic, renal, cardiac, respiratory, endocrine, or gastrointestinal systems, or any blood disorder in view of the Principal Investigator to confound the study * Female subjects those are pregnant, nursing or planning to become pregnant * Subjects receiving any experimental medications or have undergone a major surgical procedure in last 30 days * Subjects are excluded if they have previously utilized the test article (INHALE superoxygenated water) within the last 24 hours, or have undergone bariatric surgery or have received weight-loss medication * Subjects with known anemia, hemoglobinopathy or other comorbidity necessitating fluid restriction

Design outcomes

Primary

MeasureTime frameDescription
SpO2 Response RateFrom pre-ingestion to post-ingestion of waterNumber of participants who experienced an improvement in post-ingestion SpO2. An increase in post-ingestion SpO2 over the pre-ingestion level in the same subject was considered a response.
Heart Rate Response RateFrom pre-ingestion to post-ingestion of waterNumber of participants who experienced a reduction in post-ingestion heart rate. A decrease in post-ingestion heart rate over the pre-ingestion level in the same subject was considered a response.

Secondary

MeasureTime frameDescription
Energy Level Response RateFrom pre-ingestion to post-ingestion of waterNumber of participants who reported an improvement in post-ingestion energy level. An increase in post-ingestion energy level over the pre-ingestion level in the same subject was considered a response. Energy level was measured by a participant-reported questionnaire titled "Energy Level and Brain Clarity Assessment" with possible scores ranging from 1 (meaning "very-low") through 10 (meaning "very-high") where higher score indicated a greater energy level.
Brain Clarity Response RateFrom pre-ingestion to post-ingestion of waterNumber of participants who reported an improvement in post-ingestion brain clarity. An increase in post-ingestion brain clarity over the pre-ingestion level in the same subject was considered a response. Brain clarity was measured by a participant-reported questionnaire titled "Energy Level and Brain Clarity Assessment" with possible scores ranging from 1 (meaning "very-low") through 10 (meaning "very-high") where higher score indicated a greater brain clarity.

Countries

United States

Contacts

STUDY_DIRECTORDeepak Nayak, PhD

Participant flow

Recruitment details

A total of 60 subjects were enrolled in the study.

Pre-assignment details

The 60 enrolled subjects were randomized into two arms consisting of 30 subjects in each arm.

Baseline characteristics

Characteristic
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
3 Participants
Age, Categorical
Between 18 and 65 years
52 Participants
Age, Continuous43.5 Year
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
60 participants
Sex: Female, Male
Female
30 Participants
Sex: Female, Male
Male
14 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 300 / 30
other
Total, other adverse events
0 / 300 / 30
serious
Total, serious adverse events
0 / 300 / 30

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026